The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

THE USE OF PROTRYPTYLINE (MK-240) AS AN ANTIDEPRESSANT A PRELIMINARY REPORT

Published Online:https://doi.org/10.1176/ajp.120.6.594

1. Protryptyline (MK-240) is an effective antidepressant.

2. Its major usefulness appears to be for patients with retardation and apathy without agitation. Patients with marked agitation did poorly; in some patients agitation emerged as the depression was lifted.

3. The drug showed some promise in depressed psychoneurotic patients with obsessive compulsive defenses.

4. In some patients the preference for medications given prior to protryptyline seemed to be related to psychological considerations rather than to the physiological effects of the drug.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.